Sort
64,565 grants matching “drug discovery”
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,228,372Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
The MetaCyc and BioCyc Pathway/Genome Databases [SRI Proposal ECU 10-626]
$1,228,260Peter D Karp · Sri International · R01 · FY2012 · GM
Nuclear and Glial Dysfunction in Neurodegeneration
$1,228,125Jeffrey D Rothstein · Johns Hopkins University · R35 · FY2023 · NS
Nuclear and Glial Dysfunction in Neurodegeneration
$1,228,125Jeffrey D Rothstein · Johns Hopkins University · R35 · FY2025 · NS
Investigation On The Behavior And Related Neuro-Electrochemistry Of Potential Medications For The Treatment Of Substance Use Disorders.
$1,227,731Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2019 · DA
CENTER FOR DEVELOPMENT OF ANTI-SPERM CONTRACEPTIVES
$1,227,632Paul Primakoff · University Of California At Davis · U54 · FY2006 · HD
Phase 3 trial of inosine for Parkinson's disease - DCC
$1,227,432David Oakes · University Of Rochester · U01 · FY2016 · NS
Engineered human intestinal organoids: a modular system to model enteric disease
$1,226,729Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2015 · AI
Medical Scientist Training Program
$1,226,546Christopher S. Williams · Vanderbilt University · T32 · FY2016 · GM
The MetaCyc and BioCyc Pathway/Genome Databases [SRI Proposal ECU 10-626]
$1,226,262Peter D Karp · Sri International · R01 · FY2011 · GM
Discovery of new anti-bacteremia vaccines for anthrax
$1,225,780Macrogenics, Inc. · U01 · FY2004 · AI
Preclinical Pulmonary Fibrosis, an opportune rare disease cohort
$1,225,650David Albert Schwartz · University Of Colorado Denver · UH3 · FY2022 · HL
A Computational IMage Analysis Platform (CIMAP) for HuBMAP
$1,225,000Pinaki Sarder · University Of Florida · OT2 · FY2025 · OD
An integrated translational approach to overcome drug resistance
$1,224,938Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2021 · CA
Solvation modeling for next-gen biomolecule simulations
$1,224,745Kenneth A Dill · State University New York Stony Brook · RM1 · FY2024 · GM
Solvation modeling for next-gen biomolecule simulations
$1,224,473Kenneth A Dill · State University New York Stony Brook · RM1 · FY2022 · GM
Hereditary Causes of Nephrolithaisis and Kidney Failure
$1,224,428Dawn S Milliner · Mayo Clinic Rochester · U54 · FY2012 · DK
DartCF: The Dartmouth Cystic Fibrosis Research Center
$1,224,158Dean R Madden · Dartmouth College · P30 · FY2020 · DK
THE PET RADIOTRACER TRANSLATION AND RESOURCE CENTER (PET-RTRC)
$1,224,033Robert J Gropler · Washington University · P41 · FY2018 · EB
NATURAL INHIBITORS OF CARCINOGENESIS
$1,223,889University Of Illinois At Chicago · P01 · FY2000 · CA
Molecular Mechanisms Of The Autoimmune Lymphoproliferative Syndrome And Other Immunoregulatory Disorders
$1,223,848Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Discovery and development of lineage-restricted pediatric cancer surfaceome immunotherapeutic targets
$1,223,848John M Maris · Children'S Hosp Of Philadelphia · U54 · FY2018 · CA
AL-ALI (UNIVERSITY OF MIAMI, SCHOOL OF MEDICINE) - MCSP - EXPLORATORY CHEMISTRY (EC)
$1,223,763Keith Barnes · Albany Molecular Research, Inc. · N01 · FY2023 · DA
TREAT AD Admin
$1,223,221Allan I Levey · Emory University · U54 · FY2024 · AG
Stem cells for therapeutics discovery in genetic blood disorders
$1,223,081George Q Daley · Boston Children'S Hospital · U01 · FY2021 · HL